Search Results for 'amyris'

T Minus 90. Amyris’ next 90 days will say much, and may say all

T Minus 90. Amyris’ next 90 days will say much, and may say all

May 21, 2017 |

Moving fast, but will escape velocity be reached? Amyris reports 164% product revenue jump — yet questions linger. In California, Amyris reported Q1 revenues of $13.0M compared with $8.8M for Q1 2016, and touted the “significant increase in product sales, primarily in the personal care and health and nutrition markets, offset by a slight decline […]

Read More

First $47 million investment tranche led by Royal DSM into Amyris closed

First $47 million investment tranche led by Royal DSM into Amyris closed

May 15, 2017 |

In California, Amyris, Inc. announced the closing of the first tranche of up to $95 million in planned equity financing that the company previously announced on May 8, 2017. The first tranche was approximately $47 million and was led by Koninklijke DSM N.V. (Royal DSM) with participation by qualified institutional buyers and accredited investors, including […]

Read More

Amyris says “double the revenue” in sight with Nenter Vitamin E Partnership as DSM Vitamin A partnership unveiled

Amyris says “double the revenue” in sight with Nenter Vitamin E Partnership as DSM Vitamin A partnership unveiled

May 11, 2017 |

In California, Amyris said it expects revenue related to its Vitamin E partnership with Nenter to more than double based on the current success of the program. During 2016, the company shipped approximately $9 million of farnesene to Nenter for conversion to Vitamin E and expects 2017 shipments to Nenter to be about $20 million. […]

Read More

DSM invests $25 million in Amyris

DSM invests $25 million in Amyris

May 8, 2017 |

In California, Amyris, Inc. the industrial bioscience company, and Koninklijke DSM N.V., the global science-based company active in health, nutrition and materials, announced that they have agreed for DSM to make an equity investment in Amyris. At the same time, the companies will enter into a development cooperation focused on products for the global health […]

Read More

DSM invests in Amyris

DSM invests in Amyris

May 8, 2017 |

In California, DSM led a round of investors that will put up to $95 million in equity financing into Amyris via a registered direct offering of convertible preferred stock, and private placements of convertible preferred stock and warrants. Amyris is in the process of reducing its debt by approximately $75 million. DSM has agreed to […]

Read More

Amyris Joins the Sweet Fleet, and DARPA lends a hand

Amyris Joins the Sweet Fleet, and DARPA lends a hand

May 3, 2017 |

Back in September 2015, we reported that Amyris inked a multi-year agreement with the US Defense Advance Research Projects Agency, the famed DARPA that gave us everything from kevlar to the Global Positioning System and the Internet — the goal in this $35M agreement with the Biological Technologies Office was to create new research and […]

Read More

Amyris teams with Blue California to manufacture ingredients in China

Amyris teams with Blue California to manufacture ingredients in China

April 19, 2017 |

In California, Amyris announced that it has expanded the scope of its relationship with Phyto Tech Corp (D/B/A “Blue California”). Blue California is based in Southern California and is a global leader in food, flavor and fragrance ingredients and nutraceuticals. Amyris No Compromise® ingredients into China have been more than doubling in sales and are […]

Read More

Here comes BioChina: Amyris, others bypass the 4 Myths of Business in the Middle Kingdom

Here comes BioChina: Amyris, others bypass the 4 Myths of Business in the Middle Kingdom

April 18, 2017 |

From California arrives the very interesting news that Amyris has entered into an agreement with Blue California whereby its affiliates will provide access to its fermentation manufacturing in China and provide the necessary capital to produce No Compromise ingredients for Amyris.  Turns out that China sales have been doubling. Blue California might seem an unlikely […]

Read More

Amyris’s Biossance sees record sales in Q1: bullish 2017 outlook

Amyris’s Biossance sees record sales in Q1: bullish 2017 outlook

April 16, 2017 |

In California, Amyris achieved record first-quarter product sales for its Biossance brand, which is delivering high-growth and is expected to drive much better than expected 2017 results for this business line. Biossance Squalane + Peptide Eye Gel is the #1 selling eye product at SEPHORA.com and the brand’s products are garnering top reviews from leading […]

Read More

Let’s Get Tacky: Cray Valley launches new sticky resin based on Amyris tech

Let’s Get Tacky: Cray Valley launches new sticky resin based on Amyris tech

April 5, 2017 |

In France, Cray Valley has launched new tackifying resins produced with Amyris’ biologically derived Biofene branded farnesene. Tack is the measure of stickiness — vital to everything from adhesives that need to hold things in place to inks that need to stay on the printed page. According to independent market research firm, MarketsandMarkets.com, the global […]

Read More